文献速递类风湿关节炎

波形蛋白氨甲酰化可由吸烟诱导,并作为类风湿关节炎的独立自身抗原

Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2017-02-09

该研究探讨吸烟通过氨甲酰化修饰波形蛋白及其在类风湿关节炎(RA)中的自身抗原作用。动物实验显示烟雾暴露小鼠可检测到氨甲酰化波形蛋白并产生针对氨甲酰化抗原的广泛免疫反应;RA患者中吸烟者抗氨甲酰化抗体滴度显著高于非吸烟者,且早期RA中抗氨甲酰化波形蛋白抗体可独立于ACPA出现。结论提示氨甲酰化波形蛋白是吸烟可诱导的独立自身抗原,RA针对修饰抗原的免疫反应并非仅限瓜氨酸化。

要点

  • 吸烟可诱导波形蛋白氨甲酰化,烟雾暴露小鼠产生针对氨甲酰化抗原的免疫反应。
  • RA吸烟者抗氨甲酰化抗体滴度显著高于非吸烟者,但阳性率相似。
  • 早期RA中抗氨甲酰化波形蛋白抗体可独立于ACPA出现。

核心结论

  • 波形蛋白氨甲酰化可由香烟烟雾暴露诱导。
  • RA患者对修饰抗原的免疫反应并非仅限瓜氨酸特异性,氨甲酰化抗原可能参与疾病发病机制。

研究设计与样本

  • 研究在动物模型(兔免疫、小鼠烟雾暴露)中分析波形蛋白氨甲酰化及自身抗体形成。
  • 在RA患者中按病程和吸烟状态分析针对波形蛋白不同异构体的抗体反应。

主要发现

  • 波形蛋白酶促氨甲酰化可高效实现,且不干扰后续瓜氨酸化。
  • 用氨甲酰化波形蛋白免疫的兔血清除识别氨甲酰化波形蛋白外,还识别人IgG-Fc,显示类风湿因子样反应性。
  • 烟雾暴露小鼠可检测到氨甲酰化波形蛋白,并产生针对氨甲酰化抗原的广泛免疫反应。
  • 吸烟与非吸烟RA患者抗氨甲酰化抗体阳性率相似,但吸烟RA患者血清中抗氨甲酰化抗体滴度显著升高。
  • 早期RA中抗氨甲酰化波形蛋白抗体独立于ACPA出现,抗MCV与抗氨甲酰化波形蛋白双阳性患者对MCV表位识别谱扩展。

关键数值与推荐

  • 吸烟与非吸烟RA患者抗氨甲酰化抗体阳性率相似,但吸烟RA患者抗氨甲酰化抗体滴度显著升高。
  • 抗氨甲酰化波形蛋白抗体在早期RA中独立于ACPA出现。

临床怎么用

  • 对RA患者应关注吸烟状态,其与氨甲酰化抗原免疫反应相关。
  • 早期RA中抗氨甲酰化波形蛋白抗体可作为独立于ACPA的血清学标志物参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Smoking has been connected to citrullination of antigens and formation of anti-citrullinated peptide antibodies (ACPAs) in rheumatoid arthritis (RA). Since smoking can modify proteins by carbamylation (formation of homocitrulline), this study was conducted to investigate these effects on vimentin in animal models and RA. METHODS: The efficiency of enzymatic carbamylation of vimentin was characterised. B-cell response was investigated after immunisation of rabbits with different vimentin isoforms. Effects of tobacco smoke exposure on carbamylation of vimentin and formation of autoantibodies were analysed in mice. The antibody responses against isoforms of vimentin were characterised with respect to disease duration and smoking status of patients with RA. RESULTS: Enzymatic carbamylation of vimentin was efficiently achieved. Subsequent citrullination of vimentin was not disturbed by homocitrullination. Sera from rabbits immunised with carbamylated vimentin (carbVim), in addition to carbVim also recognised human IgG-Fc showing rheumatoid factor-like reactivity. Smoke-exposed mice contained detectable amounts of carbVim and developed a broad immune response against carbamylated antigens. Although the prevalence of anti-carbamylated antibodies in smokers and non-smokers was similar, the titres of carbamylated antibodies were significantly increased in sera of smoking compared with non-smoking RA. CarbVim antibodies were observed independently of ACPAs in early phases of disease and double-positive patients for anti-mutated citrullinated vimentin (MCV) and anti-carbVim antibodies showed an extended epitope recognition pattern towards MCV. CONCLUSIONS: Carbamylation of vimentin is inducible by cigarette smoke exposure. The polyclonal immune response against modified antigens in patients with RA is not exclusively citrulline-specific and carbamylation of antigens could be involved in the pathogenesis of disease. TRIAL REGISTRATION NUMBER: ISRCTN36745608; EudraCT Number: 2006-003146-41.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ospelt C, Bang H, Feist E, et al. Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28183721. doi:10.1136/annrheumdis-2016-210059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。